These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23668810)

  • 1. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals.
    Hon CY; Teschke K; Chu W; Demers P; Venners S
    J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
    Hon CY; Teschke K; Shen H; Demers PA; Venners S
    Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.
    Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S
    Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals.
    Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N
    Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
    Hedmer M; Tinnerberg H; Axmon A; Jönsson BA
    Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces.
    Hedmer M; Jönsson BA; Nygren O
    J Environ Monit; 2004 Dec; 6(12):979-84. PubMed ID: 15568047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals.
    Poupeau C; Tanguay C; Caron NJ; Bussières JF
    J Oncol Pharm Pract; 2018 Jan; 24(1):9-17. PubMed ID: 27799608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of surface contamination by antineoplastic drugs with different working conditions in hospital pharmacies.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Synek S; Blaha L
    Arch Environ Occup Health; 2014; 69(3):148-58. PubMed ID: 24325745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination.
    Bobin-Dubigeon C; Amiand M; Percheron C; Audeval C; Rochard S; Leynia P; Bard JM
    J Anal Toxicol; 2013 Sep; 37(7):433-9. PubMed ID: 23828102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.
    Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L
    Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement.
    Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C
    Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: a pilot study.
    Hon CY; Chua PP; Danyluk Q; Astrakianakis G
    J Oncol Pharm Pract; 2014 Jun; 20(3):210-6. PubMed ID: 23929731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.